Clinical Trials Browser

Metastatic Castration-Resistant Prostate Cancer (mCRPC) × enzalutamide × 1 year × Clear all

NCT06126731 2025-11-24

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Phase 1/2 Recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT04015622 2025-08-20

PROTRACT

Phase 2 Active not recruiting

Metastatic Castration-Resistant Prostate Cancer (mCRPC)